Get alerts for new trials in your area by subscribing now
New
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Location: The Bronx NY, New York NY, Bel Air MD, Glen Burnie MD,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07452458
Phase3, Recruiting
Active & ResponsiveNew
Study of Oral Food Challenge Biomarkers (SAFER)
for
Allergy
Location: New York NY, Baltimore MD, Chapel Hill NC, Nashville TN,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 1 - 17
Code: NCT07279467
Recruiting
Active & ResponsiveNew
Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis
for
Clinical High Risk for Psychosis (CHR)
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 14 - 35
Code: NCT06928935
Recruiting
New
A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
for
Glabellar Lines
Location: Chestnut Hill MA, Wilmington NC, Nashville TN,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07756580
Phase1, Recruiting
Active & ResponsiveNew
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 4 - 34
Code: NCT07216391
Phase2, Recruiting
New
Breast Artery Calcification (BAC) and Female Cardiovascular Disease
for
Cardiovascular Health Risk Communication,
Location: Manhasset NY
Sponsor: Northwell Health
Sex: Female
Age: 55 - 65
Code: NCT07809932
Recruiting
New
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
for
Secondary Immune Deficiency
Location: Bethesda MD, Coral Springs FL
Sponsor: CSL Behring
Sex: All
Age: 18+
Code: NCT07648264
Phase3, Recruiting
Active & ResponsiveNew
Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina
for
Opioid Use Disorder, Digital Health Intervention, Telemedicine,
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT07810322
Recruiting
New
Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study